Project Grant R01AI195722
- Federal Project Grant Award Summary The University of Pennsylvania received a $109,076 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective January 23, 2026, through August 31, 2029. This research grant supports investigator-initiated biomedical research focused on understanding T cell trafficking mechanisms in cryptosporidium infection. The project employs novel molecular tools...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pennsylvania $446,875 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 16, 2025, for a project extending through August 31, 2027. This Project Grant funds investigator-initiated biomedical research aimed at advancing understanding of filoviral pathogenic mechanisms and identifying novel antiviral targets. The research specifically examines...
- Federal Project Grant Award Summary The University of Pennsylvania received a $3.20 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 24, 2025, with a completion date of June 30, 2029. This research project will define the molecular and cellular mechanisms of non-canonical inflammasome responses to lipopolysaccharide (LPS) in both mouse and human models. The...
- Federal Grant Award Summary The University of Pennsylvania received a $480,249 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. This award supports research investigating the extracellular matrix (ECM) as a determinant of filovirus infectivity, specifically examining how ECM composition and stiffness influence Ebola virus (EBOV) and Marburg...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Trustees of The University of Pennsylvania a Project Grant totaling $803,591 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 3, 2026 through January 31, 2031. This research initiative focuses on developing shiv-infected rhesus macaques as a preclinical model for human immunodeficiency virus type 1 (HIV-1) broadly neutralizing antibodies...
- Federal Grant Award Summary The University of Pennsylvania received a $434,375 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with a completion date of July 31, 2027. This research project will investigate retroelement-mediated cis-regulation of embryonic hematopoiesis, specifically examining how retrotransposon-derived long terminal repeats function as...
- Federal Project Grant Award Summary The University of Pennsylvania received a $822,015 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 6, 2025, with a completion date of July 31, 2026. The grant funds the development of novel statistical methodologies to address critical methodological challenges in infectious disease research, specifically causal identification theory...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pennsylvania a $3.64 million Project Grant on July 8, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop immunoengineering strategies for durable control of human immunodeficiency virus (HIV) replication. The award supports a multi-project consortium through May 31, 2030, aimed at advancing chimeric antigen receptor (CAR) T cell therapy as...
- Federal Grant Award Summary The University of Pennsylvania received a $194,940 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 12, 2025 through July 31, 2030. This research project, titled "Macrophage Expression Quantitative Trait Loci and Tuberculosis Pathogenesis," will deliver scientific research aimed at identifying and characterizing genetic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Pennsylvania $196,020.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a Project Grant effective April 14, 2026, with completion targeted for March 31, 2031. This research initiative will investigate the impact of mechanical circulatory support (MCS) and microbiome changes on outcomes in heart transplant recipients, addressing a critical gap in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $627,483 Project Grant to the University of Pennsylvania under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period April 1, 2026 through March 31, 2031. This research initiative will generate scientific knowledge regarding how environmental perturbations determine the duration of enteric viral infections, specifically examining murine astrovirus (MuAstV) persistence mechanisms in animal models. The project will produce research findings on viral immune evasion strategies, the role of goblet cells as potential immune-privileged niches, and the glucocorticoid-CD8 T cell axis in stress-induced viral clearance, with particular focus on how routine environmental stressors such as cage change procedures influence infection outcomes. The research will deliver fundamental mechanistic insights applicable to understanding human enteric viral infections and prolonged shedding phenomena observed with previously non-persistent RNA viruses. The findings are expected to elucidate how stress responses and glucocorticoid signaling modulate immune system reactions to viral pathogens, potentially informing clinical understanding of persistent infections and transmission dynamics. Research will be conducted at the University of Pennsylvania's facility in Philadelphia, PA, and will contribute to NIAID's broader mission of advancing biomedical research addressing infectious diseases and related immunologic disorders.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $627.5k | 3/30/26 |